MFS
CCCC icon

Mirabella Financial Services’s C4 Therapeutics CCCC Stock Holding History

Mirabella Financial Services’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,400
Closed -$104K – 523
2023
Q4 		$104K Buy
+18,400
New +$42K 0.01% 399

Other funds holding CCCC

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirabella Financial Services's CCCC Position: Q1 2024 in Review

Mirabella Financial Services sold out of C4 Therapeutics (CCCC) in Q1 2024, closing a stake of 18,400 shares — an estimated $104K sold.

Mirabella Financial Services first reported a position in CCCC in Q4 2023 and held it in 1 quarter. The position peaked at $104K in Q4 2023. 106 funds tracked by Wall St. Rank hold CCCC as of Q1 2024.

  • Mirabella Financial Services reported no remaining C4 Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 18,400 C4 Therapeutics shares in Q1 2024, an estimated $104K.
  • Mirabella Financial Services first reported a position in C4 Therapeutics in Q4 2023 and held it in 1 quarter.
  • Mirabella Financial Services's C4 Therapeutics position peaked at $104K in Q4 2023.
  • 106 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2024.

Based on Mirabella Financial Services's 13F filing for Q1 2024, filed 15 May 2024.